FDA
-
-
-
-
-
-
-
MiNK Therapeutics (INKT) Announces Clinical Data on agenT-797
-
-
-
-
-
-
-
MiNK Therapeutics Announces 77% Survival Rate in Intubated Patients with COVID-19 Respiratory Failure Treated with AgenT-797
-
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

